OncoTalks | Oncology Insights at Your Fingertips
OncoTalks is the podcast for community oncology providers and clinicians who want to stay on top of new treatments and the latest advancements in oncology. Join Ontada Learn, and community oncologists from The US Oncology Network, as they explore oncology with a focus on the latest breakthroughs in cancer care. Expect concise, impactful discussions with practical clinical insights tailored for the real-world community oncology setting. Additionally, don’t miss OncoTalks Case Journeys, where experts deep dive into oncology patient cases and treatment journeys. Join as they conduct comprehensive case reviews, explore key learnings, and discuss the latest research and advances related to each case. Tune in to OncoTalks and start unlocking pathways to better patient care today!
Listen on:
Episodes
Friday Sep 13, 2024
Friday Sep 13, 2024
Welcome to episode three of three. In this episode, Dr. Alex Spira and Dr. Josh Zabari, both experts in thoracic oncology, delve into the common side effects experienced by patients undergoing treatment for locally Advanced or Metastatic EGFR+ Non-Small Cell Lung Cancer (NSCLC). They discuss the importance of early identification and management of these side effects to optimize patient care and prevent treatment discontinuation. Listen in to review strategies for addressing dermatologic and gastrointestinal toxicities, the role of multidisciplinary teams, and the significance of continuous communication with patients and caregivers.
Friday Sep 13, 2024
Friday Sep 13, 2024
Welcome to episode two of three, where Dr. John Hamack from MD Anderson Cancer Center and Dr. Millie Doss from Stanford University discuss the latest advancements and ongoing challenges in treating locally Advanced or Metastatic EGFR+ Non-Small Cell Lung Cancer (NSCLC). Explore the unmet needs in first-line therapy, the variety of resistance mechanisms, and the evolving landscape of treatment strategies.
Friday Sep 13, 2024
Friday Sep 13, 2024
Welcome to episode one of three, where we dive deep into the challenges and advancements in managing locally Advanced or Metastatic EGFR+ Non-Small-Cell Lung Cancer (NSCLC). Join Dr. Mark Socinski, Executive Medical Director of the Advent Health Cancer Institute, and Dr. David Waterhouse from Oncology Hematology Care in Cincinnati, Ohio, as they discuss the importance of biomarker testing, the evolution of treatment strategies, and the impact of effective first-line therapies on patient outcomes.